[1] |
Giusti I, D′Ascenzo S, Mancò A, et al. Platelet concentration in platelet-rich plasma affects tenocyte behavior in vitro[J]. Biomed Res Int, 2014, 2014:630870.
|
[2] |
Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis[J]. Nat Rev Rheumatol, 2013, 9(12):721-730.
|
[3] |
冯光,郝岱峰,褚万立,等. 自体单采富血小板血浆凝胶临床制作与应用[J/CD]. 中华损伤与修复杂志(电子版), 2016, 11(5):334-339.
|
[4] |
Papait A, Cancedda R, Mastrogiacomo M, et al. Allogeneic platelet-rich plasma affects monocyte differentiation to dendritic cells causing an anti-inflammatory microenvironment, putatively fostering wound healing[J]. J Tissue Eng Regen Med, 2018, 12(1):30-43.
|
[5] |
Andia I, Maffulli N. Platelet-rich Plasma for Muscle Injury and Tendinopathy[J]. Sports Med Arthrosc Rev, 2013, 21(4):191-198.
|
[6] |
Li H, Li B. PRP as a new approach to prevent infection: preparation and in vitro antimicrobial properties of PRP[J]. J Vis Exp, 2013(74).
|
[7] |
褚万立,郝岱峰,赵景峰,等. 富血小板血浆治疗深部胸骨切口感染一例并文献回顾[J/CD]. 中华损伤与修复杂志(电子版), 2017, 12(1):46-51.
|
[8] |
Picard F, Hersant B, Bosc R, et al. The growing evidence for the use of platelet-rich plasma on diabetic chronic wounds: A review and a proposal for a new standard care[J]. Wound Repair Regen, 2015, 23(5):638-643.
|
[9] |
Greppi N, Mazzucco L, Galetti G, et al. Treatment of recalcitrant ulcers with allogeneic platelet gel from pooled platelets in aged hypomobile patients[J]. Biologicals, 2011, 39(2):73-80.
|
[10] |
Kon E, Filardo G, Delcogliano M, et al. Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagen-hydroxyapatite scaffold in a sheep model[J]. BMC Musculoskelet Disord, 2010, 11:220.
|
[11] |
Zhang ZY, Huang AW, Fan JJ, et al. The Potential Use of Allogeneic Platelet Rich Plasma for Large Bone Defect Treatment Immunogen city and Defect Healing Efficacy[J]. Cell Transplant, 2013, 22(1):175-187.
|
[12] |
刘景汉,欧阳锡林,庄远,等. -80 ℃长期保存血小板的可行性研究[J]. 中国输血杂志,2008, 21(4):243-245.
|
[13] |
Anitua E, Prado R, Orive G. Allogeneic Platelet-Rich Plasma: At the Dawn of an Off-the-Shelf Therapy[J]. Trends Biotechnol, 2017, 35(2):91-93.
|
[14] |
Papait A, Cancedda R, Mastrogiacomo M, et al. Allogeneic platelet-rich plasma affects monocyte differentiation to dendritic cells causing an anti-inflammatory microenvironment, putatively fostering wound healing[J]. J Tissue Eng Regen Med, 2018, 12(1):30-43.
|
[15] |
Sonker A, Dubey A, Bhatnagar A, et al. Platelet growth factors from allogeneic platelet-rich plasma for clinical improvement in split-thickness skin graft[J]. Asian J Transfus Sci, 2015, 9(2):155-158.
|
[16] |
Jo CH, Shin JS, Lee SY, et al. ALLOGENEIC PLATELET-RICH PLASMA FOR ROTATOR CUFF REPAIR[J]. Acta Ortop Bras, 2017, 25(1):38-43.
|
[17] |
Zhang ZY, Huang AW, Fan JJ, et al. The potential use of allogeneic platelet-rich plasma for large bone defect treatment: immunogenicity and defect healing efficacy[J]. Cell Transplant, 2013, 22(1):175-187.
|
[18] |
Santoso S. Human platelet alloantigens[J]. Transfus Apher Sci, 2003, 28(3):227-236.
|
[19] |
Rozman P. Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantation[J]. Transpl Immunol, 2002, 10(2/3):165-181.
|
[20] |
Harris PE, Cortesini R, Suciu-Foca N. Indirect allorecognition in solid organ transplantation[J]. Rev Immunogenet, 1999, 1(3):297-308.
|
[21] |
Marino J, Paster J, Benichou G. Allorecognition by T Lymphocytes and Allograft Rejection[J]. Front Immunol, 2016, 7:582.
|
[22] |
Pieri F, Lucarelli E, Corinaldesi G, et al. Effect of Mesenchymal Stem Cells and Platelet-Rich Plasma on the Healing of Standardized Bone Defects in the Alveolar Ridge: A Comparative Histomorphometric Study in Minipigs[J]. J Oral Maxillofac Surg, 2009, 67(2):265-272.
|